| Bioactivity | MLKL-IN-2 is a MLKL inhibitor extracted from patent WO2021224505A1, compound (i)[1]. | ||||||||||||
| Target | MLKL | ||||||||||||
| Name | MLKL-IN-2 | ||||||||||||
| CAS | 899759-16-1 | ||||||||||||
| Formula | C26H25N5O | ||||||||||||
| Molar Mass | 423.51 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Sáez AJG, et, al. Modulation of mixed lineage kinase domain-like protein signaling. WO2021224505A1. |